Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2733982240;82241;82242 chr2:178564117;178564116;178564115chr2:179428844;179428843;179428842
N2AB2569877317;77318;77319 chr2:178564117;178564116;178564115chr2:179428844;179428843;179428842
N2A2477174536;74537;74538 chr2:178564117;178564116;178564115chr2:179428844;179428843;179428842
N2B1827455045;55046;55047 chr2:178564117;178564116;178564115chr2:179428844;179428843;179428842
Novex-11839955420;55421;55422 chr2:178564117;178564116;178564115chr2:179428844;179428843;179428842
Novex-21846655621;55622;55623 chr2:178564117;178564116;178564115chr2:179428844;179428843;179428842
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: C
  • RefSeq wild type transcript codon: TGT
  • RefSeq wild type template codon: ACA
  • Domain: Ig-140
  • Domain position: 62
  • Structural Position: 144
  • Q(SASA): 0.1286
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
C/Y None None 0.999 N 0.789 0.417 0.764677420096 gnomAD-4.0.0 4.10525E-06 None None None None N None 0 0 None 0 0 None 0 0 4.49748E-06 0 1.65667E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
C/A 0.2642 likely_benign 0.295 benign -1.166 Destabilizing 0.469 N 0.274 neutral None None None None N
C/D 0.9856 likely_pathogenic 0.9885 pathogenic -1.734 Destabilizing 0.998 D 0.825 deleterious None None None None N
C/E 0.9949 likely_pathogenic 0.996 pathogenic -1.561 Destabilizing 0.998 D 0.827 deleterious None None None None N
C/F 0.8843 likely_pathogenic 0.8968 pathogenic -1.017 Destabilizing 0.999 D 0.775 deleterious N 0.494402516 None None N
C/G 0.2609 likely_benign 0.2795 benign -1.434 Destabilizing 0.98 D 0.735 prob.delet. N 0.490136555 None None N
C/H 0.9805 likely_pathogenic 0.9835 pathogenic -1.982 Destabilizing 1.0 D 0.815 deleterious None None None None N
C/I 0.7593 likely_pathogenic 0.7873 pathogenic -0.485 Destabilizing 0.998 D 0.785 deleterious None None None None N
C/K 0.997 likely_pathogenic 0.9975 pathogenic -0.908 Destabilizing 0.998 D 0.814 deleterious None None None None N
C/L 0.7963 likely_pathogenic 0.808 pathogenic -0.485 Destabilizing 0.985 D 0.634 neutral None None None None N
C/M 0.8966 likely_pathogenic 0.8938 pathogenic -0.188 Destabilizing 1.0 D 0.76 deleterious None None None None N
C/N 0.9162 likely_pathogenic 0.9274 pathogenic -1.346 Destabilizing 0.999 D 0.819 deleterious None None None None N
C/P 0.9715 likely_pathogenic 0.9728 pathogenic -0.688 Destabilizing 0.998 D 0.825 deleterious None None None None N
C/Q 0.985 likely_pathogenic 0.9869 pathogenic -1.073 Destabilizing 0.999 D 0.827 deleterious None None None None N
C/R 0.9737 likely_pathogenic 0.9779 pathogenic -1.249 Destabilizing 0.997 D 0.813 deleterious N 0.51301375 None None N
C/S 0.2545 likely_benign 0.2755 benign -1.504 Destabilizing 0.961 D 0.671 neutral N 0.488420546 None None N
C/T 0.4632 ambiguous 0.4569 ambiguous -1.184 Destabilizing 0.985 D 0.717 prob.delet. None None None None N
C/V 0.533 ambiguous 0.5713 pathogenic -0.688 Destabilizing 0.985 D 0.671 neutral None None None None N
C/W 0.9841 likely_pathogenic 0.9857 pathogenic -1.52 Destabilizing 1.0 D 0.785 deleterious N 0.513267239 None None N
C/Y 0.9588 likely_pathogenic 0.9666 pathogenic -1.156 Destabilizing 0.999 D 0.789 deleterious N 0.501657444 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.